Undertaking a Transrectal Ultrasound Guided Biopsy of the Prostate

PDF Format (119Kb)

ISBN 978 1 84463 041 7 - Published Dec 2006

The Prostate Cancer Risk Management Programme ensures that men requesting a prostate-specific antigen (PSA) test are provided with information about the benefits, limitations and risks to enable them to make an informed choice. The PCRMP is also responsible for improving the quality of PSA testing, for the quality of processes in the diagnosis of prostate cancer and for providing a systematic and standardised follow up pathway as far as the point of diagnosis.

These guidelines for transrectal ultrasound guided biopsy of the prostate were developed in association with the Department of Pathology, University of Liverpool. In addition, a systematic review was commissioned by the Centre for Reviews and Dissemination, University of York, to evaluate systematic prostate biopsy methods in the investigation for prostate cancer.

Copies of NHSBSP publications are normally free of charge for staff working within the NHS, the voluntary sector and for healthcare students. To order copies or obtain details of prices and availability of publications to those outside the NHS, please contact the Department of Health publication orderline: Telephone: 0300 123 1002, Textphone: 0300 123 1003, Fax: 01623 724 524, Email orders: [email protected] or order directly from the Department of Health Publications Orderline website.